Market Trend Si...'s  Instablog

Market Trend Signal
Send Message
Market Trend Signal™ is the leader in Trend Following, Market Timing and Stock Ratings. Clients receive access to stock ratings on over 8000 stocks as well as market timing trend following signals on all major markets and sectors. Market Trend Signal™ provides users with an easy to use market... More
My company:
Market Trend Signal
My blog:
Trend Following Stocks
My book:
Trend Following Stocks
  • Sucampo Pharmaceuticals 0 comments
    Jan 13, 2014 6:50 PM | about stocks: SCMP


    CURRENT SIGNAL - BUY on 11/15/13


    (click to enlarge)

    (click to enlarge)

    Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, discovery, development, and commercialization of proprietary drugs based on prostones and other novel drug technologies in the Americas, Europe, and Asia. It develops prostone-based drugs to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, as well as for other therapeutic applications. The company, through its commercial partner, Takeda Pharmaceutical Co., Ltd., offers AMITIZA in the United States for the treatment of chronic idiopathic constipation in adults; opioid induced constipation in adults with chronic non-cancer pain; and irritable bowel syndrome with constipation in adult women. It also provides AMITIZA in Japan through its commercial partner, Abbott Japan Co., Ltd., for chronic constipation in adults; and in the United Kingdom and Switzerland for the treatment of chronic idiopathic constipation. In addition, Sucampo Pharmaceuticals markets RESCULA in the United States for the treatment of open-angle glaucoma and ocular hypertension. The company’s pipeline also includes AMITIZA, which will begin a Phase III trial for pediatric functional constipation. Its other pipeline products consist of cobiprostone, which is in Phase I clinical development for the treatment of oral mucositis; SPI-017, which is in Phase II clinical development for the treatment of spinal stenosis; and SPI-3608, which is in Phase I clinical development for the treatment of spinal stenosis. Sucampo Pharmaceuticals, Inc. was founded in 1996 is headquartered in Bethesda, Maryland.

    Market Trend Signal
    Stock Analysis Software and Trading System

    Stocks: SCMP
Back To Market Trend Signal's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Most Commented
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.